While artificial intelligence (AI) has undoubtedly been widely embraced as a “game changer” across industries, skeptics are quick to point out AI’s limits within biopharma and healthcare. However, a closer […]
Bridging AI & Human Insights in Biopharma Markets Read More »
This first session of MM+M’s Convene Media event discussed using data analytics not just for measurement, but also to optimize engagement, leverage networks, set up feedback loops and build new
Improving Omnichannel Marketing with Pharmaceutical Analytics Read More »
Artificial Intelligence (AI) fueled by real-world healthcare data has yet to be fully leveraged by biopharmaceutical companies but is poised to revolutionize their business strategies. For example, one can use
Unlocking AI’s Power in Biopharma with Real-World Data Read More »
Rethinking Big Data Strategies in Biopharma: From Platforms to Engagement Most biopharmaceutical companies have spent the last few years focused on a Big Data strategy targeted at reducing costs and
Big Data Analytics in Biopharma: Transforming Care Read More »
Data has become a commodity within biopharma. Multiple companies have made significant strides in procuring, integrating and managing datasets for biopharma. However, one fundamental challenge remains — generating actionable insights
Enhancing Biopharma Strategy with Data Analytics Insights Read More »
Author: Timothy Hare VP, Head of Data Science, 81qd New York, NY A purely AI-driven design of drug candidates is coming into its own, as scientists discover better AI model
AI Revolutionizes Drug Design: Enhancing R&D in Biopharma Read More »